Back to today’s briefing

Story perspectives

Trump Extends Drug Price Negotiation Delay, Sparks Senior Concerns

4/17/2025

47 9

Left

Trump Delays Drug Pricing

President Trump has taken a bold step by signing an executive order that delays Medicare's drug price negotiations, extending the limit for small-molecule drugs from nine to thirteen years. This decision, catering to pharmaceutical companies, raises concerns about escalating costs for seniors. Additionally, the order introduces measures for drug importation and faster approvals for generics, promising to reshape U.S. healthcare.

Center

Biden Tackles Drug Costs

Americans are feeling the pinch of soaring drug prices, especially when compared to other nations. The Trump administration's attempt to implement “most-favored nation” pricing raised concerns about stifling innovation. A new executive order seeks to cut costs and enhance transparency, while pharmaceutical companies are looking to the EU for support amidst looming U.S. tariff threats.

1 of 2

Trump Delays Drug Pricing

President Trump has taken a bold step by signing an executive order that delays Medicare's drug price negotiations, extending the limit for small-molecule drugs from nine to thirteen years. This decision, catering to pharmaceutical companies, raises concerns about escalating costs for seniors. Additionally, the order introduces measures for drug importation and faster approvals for generics, promising to reshape U.S. healthcare.

1 / 2